19 June 2013
Keywords: ionix, xenome, sign, toxin, deal, pharmaceuticals, uk-based
Article | 11 March 2002
Ionix Pharmaceuticals, a UK-based analgesic drug discovery company, hassigned an agreement with Xenome, an Australian firm that specializes in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 March 2002
18 March 2002
18 June 2013
© 2013 thepharmaletter.com